Vertex Pays AbCellera Millions For New Drug Research

Vertex Pharmaceuticals just made a big move. They joined with AbCellera for new drug research. Vertex paid AbCellera $28 million to begin. This partnership focuses on making drugs for autoimmune diseases.

AbCellera uses a special method called a T-cell engager platform. This method helps find and create new medicines. This is not AbCellera's first big deal this summer. They are becoming a key player in drug discovery.

Autoimmune diseases cause the body's immune system to attack itself. Finding new ways to treat these conditions is very important. This new team-up could bring new hope to many patients. It shows how companies are working together to fight difficult diseases.

Source: FierceBiotech